GSK Asks Supreme Court To Weigh Double Avandia Damages

Law360, Washington (December 11, 2012, 6:30 PM EST) -- GlaxoSmithKline PLC has urged the U.S. Supreme Court to consider whether private insurers like Humana Inc. can seek double damages from the pharmaceutical giant over costs borne for Medicare patients harmed by the diabetes drug Avandia, claiming that remedy shouldn't be available to private insurers.

GSK claimed in a petition for writ of certiorari filed Dec. 5 that the Third Circuit vastly broadened the scope of the Medicare Secondary Payer Act by reviving Humana Medical Plan Inc. and Humana Insurance Co.'s federal suit against the company...
To view the full article, register now.